GeneCraft is a pre-clinical-stage biotech company dedicated to improving treatment and clinical outcomes for patients through gene therapy that harness the innate oncogene defense system.
“Life is a phenomenon of gene expression, and its imbalance causes most of the diseases we know. The most effective tool to correct this imbalance is inevitably ‘gene’. Therefore, gene therapy technology is axiomatically the most effective treatment strategy that can fundamentally treat many diseases that were incurable in the past. We earnestly wish that the gene therapy technology we pursue will let us overcome life-threatening diseases in the near future.”